Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.22.1
Stock-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Assumptions for Stock Option Grants

 

    2022     2021  
Valuation assumptions                
Expected dividend yield     0.0 %     0.0 %
Expected volatility     56.3% –69.8 %     119-123 %
Expected term (years) – simplified method     3.0 – 6.1       5.5 – 6.0  
Risk-free interest rate     1.74% – 2.13 %     0.98% – 1.12 %
Schedule of Share Option Activity

Stock option activity during the for the three-month periods ended March 31, 2022 and 2021 is as follows:

 

    Number of Options     Weighted average exercise price     Weighted average remaining contractual term  
Balance as of January 1, 2021     756,383     $ 1.82       8.7  
Granted     1,229,590       4.61          
Additional options grant StemoniX holders     292,995     4.61          
Options assumed in Merger     55,840       45.95          
Exercised     (29,916 )     1.24          
Forfeited     (29,349 )     2.00          
Expired     (7,000 )     1.39          
Balance as of March 31, 2021     2,268,543     $ 4.79       8.1  
                         
Balance as of January 1, 2022     2,320,097     4.19       7.4  
Granted     725,301       1.01          
Exercised     (5,174 )     0.96          
Forfeited     (255,766 )     4.22          
Expired     (17,842 )     57.24          
Balance as of March 31, 2022     2,766,616     $ 3.01       8.7  
                         
Exercisable as of March 31, 2022     1,011,626     $ 3.72       7.6  
Schedule of Share Based Compensation Activity

The Company recognized stock-based compensation in continuing operations related to different instruments for the three-month periods ended March 31 as follows:

 

    2022     2021  
Stock options   $ 258     $ 366  
Shares issued for services     20       -  
Total   $ 278     $ 366